Aim Major depressive disorder (MDD) is a prevalent psychiatric condition and vortioxetine
offers promising antidepressant effects due to its unique pharmacological profile. However …

Depressive symptoms are a customary finding in hospitalized patients, particularly those
who are undergoing long hospitalizations, underwent major surgical procedures or suffer …

Introduction: The troubling issues of conventional antidepressants are inadequate disease
remission and potential adverse effects. There is a dearth of research findings comparing …

This determination of the mitochondrial effect of pharmacologically different antidepressants
(agomelatine, ketamine and vortioxetine) was evaluated and quantified in vitro in pig brain …

Introduction Major depressive disorder (MDD) is a common severe mental disorder,
requiring a tailored and integrated treatment. Several approaches are available including …

Background Although vortioxetine demonstrates superior efficacy relative to placebo, there
is still a lack of robust evidence to determine whether it offers advantages over commonly …

Background and objectives: The majority of mainstream antidepressants lack the promise of
complete amelioration of symptoms. Other pitfalls include the latency period and side effects …

Objective: The study aimed to conduct a multidimensional evaluation of potential adverse
events (AEs) of escitalopram oxalate based on the FDA adverse event reporting system …

Objetivo Analizar la repercusión del antidepresivo vortioxetina sobre la función sexual,
frente a inhibidores selectivos de la recaptación de serotonina (ISRS) e inhibidores …

Short title of the paper… Aims: The FDA Adverse Event Reporting System (FAERS)
database was used to study vortioxetine-associated adverse events (ADEs) in a real-world …